1. Cell Cycle/DNA Damage Cytoskeleton Apoptosis
  2. Microtubule/Tubulin Apoptosis Caspase
  3. Microtubule destabilizing agent-2

Microtubule destabilizing agent-2 

目录号: HY-159891
产品使用指南

Microtubule destabilizing agent-2 (Compound 21) 是一种口服有效和选择性的靶向微管蛋白的抗肿瘤化合物。Microtubule destabilizing agent-2 可破坏微管蛋白稳定性,抑制微管聚合物。Microtubule destabilizing agent-2 使人肿瘤细胞 G0/G1 期停滞,通过激活 Caspase 级联途径诱导细胞凋亡 (apoptosis)。Microtubule destabilizing agent-2 还具有抗炎活性,在体外能抑制 TNF-α 和 IL-6 产生。Microtubule destabilizing agent-2 可抑制异种移植小鼠的肿瘤生长。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Microtubule destabilizing agent-2 Chemical Structure

Microtubule destabilizing agent-2 Chemical Structure

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

Microtubule destabilizing agent-2 (Compound 21) is an orally active and selective antitumor compound targeting microtubule protein. Microtubule destabilizing agent-2 destabilizes microtubule proteins and inhibits microtubule polymers. Microtubule destabilizing agent-2 arrests the G0/G1 phase in human tumor cells. Microtubule destabilizing agent-2 induces apoptosis by activating the cascade pathway of caspases. Microtubule destabilizing agent-2 has anti-inflammatory activity, as inhibiting TNF-α and IL-6 in vitro. Microtubule destabilizing agent-2 reduces tumors growth in xenograft mice[1].

IC50 & Target[1]

Caspase 3

 

体外研究
(In Vitro)

Microtubule destabilizing agent-2 (48 h) 相较于82.46 μM (MCF-7)、31.27 μM (MDA-MB-231) 的IC50,对人白血病细胞K-562具有选择性抗增殖作用 (IC50: 3.27 μM)[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

Microtubule destabilizing agent-2 (20-80 mg/kg,口服, 28天) 在 K562 异种移植小鼠模型中具有中至低度抗癌效果[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: K562 xenograft mouse model[1]
Dosage: 20, 40, 80 mg/kg.
Administration: Oral gavage (p.o.). 5 days a week for four weeks
Result: Showed weak anticancer effect at 20 mg/kg (36 % reduction) and 40 mg/kg (31.68 % reduction), but moderate effect at 80 mg/kg (47 %).
分子量

402.48

Formula

C26H26O4

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
Microtubule destabilizing agent-2
目录号:
HY-159891
需求量: